2025年6月27日 周五
首页 > 按月查看>2023年第7月 >564-572
PDF 导出
常见中药在治疗血脂异常中的研究新进展
作者:
作者单位:

(南华大学药学院药物药理研究所,湖南省衡阳市 421001)

作者简介:

李琴,硕士研究生,研究方向为心血管药理和分子药理,E-mail:1459321260@qq.com。通信作者李兰芳,教授,博士研究生导师,研究方向为心血管药理和分子药理,E-mail:llanfang6@126.com。

基金项目:

国家自然科学基金项目(81970431)


New research progress of traditional Chinese medicine in the treatment of dyslipidemia
Author:
Affiliation:

Institute of Pharmaceutical Pharmacology, School of Pharmacy, University of South China, Hengyang, Hunan 421001, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献
    • |
  • 相似文献
    • | |
    摘要:

    血脂异常是由多种复杂原因导致的人体代谢性疾病,山楂、银杏叶、绞股蓝、泽泻、虎杖作为常见中药,在治疗血脂异常中具有一定的作用。本文总结了国内外最新研究进展,综述了常见中药山楂、银杏叶、绞股蓝、泽泻、虎杖等在治疗血脂异常中的作用,提示这些中药在防治血脂异常相关疾病如动脉粥样硬化中具有十分重要的意义。

    Abstract:

    Dyslipidemia is a human metabolic disease caused by a variety of complex causes, traditional Chinese medicine crataegi folium, gynostemma pentaphyllum, alismatis rhizoma, polygoni cuspidati rhizoma et radix, and ginkgo folium have therapeutic effects on dyslipidemia. This article reviews the effects of the common traditional Chinese medicine crataegi folium, gynostemma pentaphyllum, alismatis rhizoma, polygoni cuspidati rhizoma et radix, ginkgo folium in the treatment of dyslipidemia, and suggests that these traditional Chinese medicine may have some potential advantages in the prevention and treatment of dyslipidemia-related diseases such as atherosclerosis.

    参考文献
    [1] YANG C, JIA X, WANG Y, et al.Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999-2018.BMC Geriatr, 2,2(1):979.
    [2] MACH F, BAIGENT C, CATAPANO A L, et al.2019 ESC/EAS guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk.Eur Heart J, 0,1(1):111-188.
    [3] 吴巧敏, 刘金凤, 汪艳丽, 等.刘如秀教授论治血浊经验.陕西中医, 2,3(5):624-627.WU Q M, LIU J F, WANG Y L, et al.Professor Liu Ruxiu's experience in treating hyperlipidemia.Shaanxi J Tradit Chin Med, 2,3(5):624-627.
    [4] 丁宗君.他汀类药物治疗慢性肝病的临床应用及不良反应研究进展.中国药物滥用防治杂志, 2,8(3):273-277.DING Z J.Clinical application and adverse reactions of statins in the treatment of chronic liver disease.Chin J Drug Abuse Prev Treat, 2,8(3):273-277.
    [5] 余刘勤, 贾爱梅, 宋永砚.柴胡皂苷抗炎、抗氧化和降脂研究进展.中国动脉硬化杂志, 0,8(1):87-92.YU L Q, JIA A M, SONG Y Y.Progress in the study of saikosaponins on anti-inflammation, anti-oxidation and lipid-lowering effects.Chin J Arterioscler, 0,8(1):87-92.
    [6] 王增武, 刘静, 李建军, 等.中国血脂管理指南(2023年).中国循环杂志, 3,8(3):237-271.WANG Z W, LIU J, LI J J, et al.Chinese guidelines for lipid management (2023).Chin Circ J, 3,8(3):237-271.
    [7] HAN X, ZHAO W, ZHOU Q, et al.Procyanidins from hawthorn (Crataegus pinnatifida) alleviate lipid metabolism disorder via inhibiting insulin resistance and oxidative stress, normalizing the gut microbiota structure and intestinal barrier, and further suppressing hepatic inflammation and lipid accumulation.Food Funct, 2,3(14):7901-7917.
    [8] LI H, XI Y, XIN X, et al.Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.Nutr Metab (Lond), 0,7:34.
    [9] 滕菲, 李祥溦, 李敏, 等.绞股蓝地下部位总皂苷化学成分分析及降脂作用研究.中国中药杂志, 2,7(18):5022-5031.TENG F, LI X S, LI M, et al.Components and lipid-lowering effect of total saponins from underground part of gynostemma pentaphyllum.Chin J Chin Mat Med, 2,7(18):5022-5031.
    [10] ARON-WISNEWSKY J, WARMBRUNN M V, NIEUWDORP M, et al.Metabolism and metabolic disorders and the microbiome:the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies.Gastroenterology, 0,0(2):573-599.
    [11] SCHOELER M, CAESAR R.Dietary lipids, gut microbiota and lipid metabolism.Rev Endocr Metab Disord, 9,0(4):461-472.
    [12] 李佳慧, 张丽芳, 柯元南.PCSK9抑制剂的临床研究新进展.中日友好医院学报, 3,7(1):29-30.LI J H, ZHANG L F, KE Y N.New progress in clinical research of PCSK9 inhibitors.J Chin Jpn Friendship Hosp, 3,7(1):29-30.
    [13] 国家药典委员会.中华人民共和国药典(2020版)一部.北京:中国医药科技出版社, 2020:33.Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China (2020 Edition) Part 1.Beijing:China Medical Science and Technology Press, 2020:33.
    [14] HAN Y, DU J, LI J, et al.Quantification of the organic acids in hawthorn wine:a comparison of two HPLC methods.Molecules, 9,4(11):2150.
    [15] LU R, QIN C, YANG F, et al.Grape seed proanthocyanidin extract ameliorates hepatic lipid accumulation and inflammation in grass carp(ctenopharyngodon idella).Fish Physiol Biochem, 0,6(5):1665-1677.
    [16] ABU-GHARBIEH E, SHEHAB N G.Therapeutic potentials of crataegus azarolus var.euazarolus maire leaves and its isolated compounds.BMC Complement Altern Med, 7,7(1):218.
    [17] MA K, SHENG W, GAO R, et al.Ethanolic extract of root from arctium lappa L ameliorates obesity and hepatic steatosis in rats by regulating the AMPK/ACC/CPT-1 pathway.J Food Biochem, 2,6(12):e14455.
    [18] 刁婷婷, 张雨晨, 陈创, 等.山楂叶总黄酮对高脂血症大鼠血脂的影响及其机制.医药导报, 0,9(6):757-762.DIAO T T, ZHANG Y C, CHEN C, et al.Effect and mechanism of hawthorn leaves flavonoids on blood lipid in hyperlipidemia rats.Her Med, 0,9(6):757-762.
    [19] 肖峰, 闵洁, 张雨晨, 等.山楂叶总黄酮对高脂血症大鼠心脏保护作用的实验研究.湖北科技学院学报(医学版), 1,5(3):188-192.XIAO F, MIN J, ZHANG Y C, et al.Study on the protective effect of hawthorn leaves flavonoids on the heart of hyperlipidemia rats.J Hubei Tech Univ (Med Ed), 1,5(3):188-192.
    [20] 柏婷燕, 刘凯, 赵信科, 等.基于网络药理学探讨山楂叶抗高脂血症作用机制及其分子对接验证.中医临床研究, 2,4(29):12-18.BAI T Y, LIU K, ZHAO X K, et al.A study on the action mechanism of Shanzha leaf on hyperlipidemia based on network pharmacology and its molecular docking verification.Clin J Chin Med, 2,4(29):12-18.
    [21] KWEK E, YAN C, DING H, et al.Effects of hawthorn seed oil on plasma cholesterol and gut microbiota.Nutr Metab (Lond), 2,9(1):55.
    [22] 吕立铭, 彭崇胜, 李晓波.山楂核化学成分、药理作用及应用研究进展.沈阳药科大学学报, 2,9(12):1521-1532.LV L M, PENG C S, LI S B.Research progress in chemical ingredients, pharmacological activities and application of hawthorn seeds.J Shenyang Pharm Univ, 2,9(12):1521-1532.
    [23] SHATOOR A S.Acute and sub-acute toxicity of Crataegus Aronia Syn.Azarolus (L.) whole plant aqueous extract in wistar rats.Am J Pharmacol Toxicol, 1,6(2):37-45.
    [24] 付满玲, 黄雨佳, 刘珉甬, 等.山楂代用茶对大鼠经口急性毒性实验.医学信息, 0,3(1):77-80.FU M L, HUANG Y J, LIU M Y, et al.Experimental on oral acute toxicity of hawthorn substitute tea on rats.J Med Inform, 0,3(1):77-80.
    [25] SU C, LI N, REN R, et al.Progress in the medicinal value, bioactive compounds, and pharmacological activities of gynostemma pentaphyllum.Molecules, 1,6(20):6249.
    [26] HUANG Y, WANG Y, LIU Y, et al.Chemical characterization and atherosclerosis alleviation effects of gypenosides from gynostemma pentaphyllum through ameliorating endothelial dysfunction via the PCSK9/LOX-1 pathway.J Agric Food Chem, 2,0(38):11944-11957.
    [27] 雷婧, 许韩婷, 苏洁, 等.不同含量绞股蓝皂苷对高脂血症大鼠血脂的影响.上海中医药大学学报, 4,8(2):60-64.LEI J, XU H T, SU J, et al.Effect of different contents of gypenoside saponins on blood lipid of rats with hyperlipidemia.Acad J Shanghai Univ Tradit Chin Med, 4,8(2):60-64.
    [28] LEE H S, LIM S, JUNG J I, et al.Gynostemma pentaphyllum extract ameliorates high-fat diet-induced obesity in C57BL/6N mice by upregulating SIRT1.Nutrients, 9,1(10):2475.
    [29] YANG C, ZHAO Y, REN D, et al.Protective effect of saponins-enriched fraction of gynostemma pentaphyllum against high choline-induced vascular endothelial dysfunction and hepatic damage in mice.Biol Pharm Bull, 0,3(3):463-473.
    [30] CHIRANTHANUT N, TEEKACHUNHATEAN S, PANTHONG A, et al.Toxicity evaluation of standardized extract of gynostemma pentaphyllum Makino.J Ethnopharmacol, 3,9(1):228-234.
    [31] CHOI E, WON Y H, KIM S, et al.Supplementation with extract of gynostemma pentaphyllum leaves reduces anxiety in healthy subjects with chronic psychological stress:a randomized, double-blind, placebo-controlled clinical trial.Phytomedicine, 8,2:198-205.
    [32] JIA L, ZHANG M, WANG P, et al.Alismatis rhizoma methanolic extract-effects on metabolic syndrome and mechanisms of triterpenoids using a metabolomic and lipidomic approach.Front Pharmacol, 2,3:983428.
    [33] CHEN Q, CHAO Y, ZHANG W, et al.Activation of estrogen receptor α (ERα) is required for alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation.Life Sci, 0,8:118030.
    [34] DAN H, WU J, PENG M, et al.Hypolipidemic effects of alismatis rhizome on lipid profile in mice fed high-fat diet.Saudi Med J, 1,2(7):701-707.
    [35] XU X, LI L, ZHANG Y, et al.Hypolipidemic effect of alisma orientale (Sam.) Juzep on gut microecology and liver transcriptome in diabetic rats.PLoS One, 0,5(10):e0240616.
    [36] LEE M, JUNG H, LEE K, et al.A 90-day repeated oral dose toxicity study of alismatis rhizoma aqueous extract in rats.Toxicol Res, 9,5(2):191-200.
    [37] SU C, WANG H, TSAI M, et al.Protective effect of microorganism biotransformation-produced resveratrol on the high fat diet-induced hyperlipidemia, hepatic steatosis and synaptic impairment in hamsters.Int J Med Sci, 2,9(10):1586-1595.
    [38] Lü S, DANG G, DENG J, et al.Shikonin attenuates hyperhomocysteinemia-induced CD4＋T cell inflammatory activation and atherosclerosis in ApoE－/－ mice by metabolic suppression.Acta Pharmacol Sin, 9,1(1):47-55.
    [39] ZHOU L, LONG J, SUN Y, et al.Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE－/－ mice and inhibits the activation of CD4＋ T cells.Nutr Metab (Lond), 0,7:41.
    [40] JING Y, HU T, LIN C, et al.Resveratrol downregulates PCSK9 expression and attenuates steatosis through estrogen receptor α-mediated pathway in L02 cells.Eur J Pharmacol, 9,5:216-226.
    [41] TAO T, ZHANG Q, LIU Z, et al.Polygonum cuspidatum extract exerts antihyperlipidemic effects by regulation of PI3K/Akt/FOXO3 signaling pathway.Oxid Med Cell Longevity, 1,1:3830671.
    [42] 吉秋霞, 许晓乐.虎杖苷对高脂喂养的中年LDLR－/－小鼠非酒精性脂肪肝炎的作用及机制研究.中草药, 1,2(12):3602-3610.JI Q X, XU X L.Effect of polydatin on age-and diet-associated non-alcoholic steatohepatitis in LDL receptor knockout mice and its possible mechanisms.Chin Tradit Herb Drugs, 1,2(12):3602-3610.
    [43] 白雨鑫, 童荣生, 李晋齐, 等.虎杖解毒颗粒(无糖型)的药效毒理学研究.实用药物与临床, 2,5(5):438-441.BAI Y X, TONG R S, LI J Q, et al.Effects and toxicologic study of Huzhang antidote granules (sugar-free).Pract Pharm Clin Rem, 2,5(5):438-441.
    [44] 王呈谕, 刘晓璇, 李轶群, 等.何首乌、虎杖、大黄水提物中游离蒽醌含量的测定及对人正常肝细胞的毒性作用.癌变·畸变·突变, 0,2(3):215-220.WANG C Y, LIU X X, LI Y Q, et al.Toxicity of polygoni multiflori radix, polygoni cuspidati rhizoma et radix and rhei radix et rhizoma in HepaRG cells.Teratog carcinog mutagen, 0,2(3):215-220.
    [45] LIU L, WANG Y, ZHANG J, et al.Advances in the chemical constituents and chemical analysis of Ginkgo biloba leaf, extract, and phytopharmaceuticals.J Pharm Biomed Anal, 0,3:113704.
    [46] 刘丽娜, 李海亮, 李耀磊, 等.银杏叶片中5种银杏双黄酮类成分同时测定方法的建立.中国药房, 2,3(10):1220-1224.LIU L N, LI H L, LI Y L, et al.Establishment of determination method for five Ginkgo biflavones in Ginkgo biloba leaves tablets.China Pharm, 2,3(10):1220-1224.
    [47] SU C, YANG C, GONG M, et al.Antidiabetic activity and potential mechanism of amentoflavone in diabetic mice.Molecules, 9,4(11):2184.
    [48] 许麦成, 程新梅, 马吕丽.银杏叶提取物调节高脂血症大鼠模型血脂的有效剂量研究.中草药, 1,2(2):454-458.XU M C, CHENG X M, MA L L.Study on effective dosages of ginkgo leaf extracts on regulating blood lipid of hyperlipidemia rats.Chin Tradit Herb Drugs, 1,2(2):454-458.
    [49] 杨志晖, 袁海龙, 葛华, 等.银杏叶提取物对重复+Gz暴露高脂血症大鼠主动脉LOX-1及NF-κB表达的影响.空军医学杂志, 7,3(6):361-365.YANG Z H, YUAN H L, GE H, et al.Effect of GBE on expressions of LOX-1 and NF-кB in aortas of hyperlipidemicrats exposed to repeated positive acceleration.Avia Med Air Force, 7,3(6):361-365.
    [50] KOCH E, NLDNER M, LEUSCHNER J.Reproductive and developmental toxicity of the Ginkgo biloba special extract EGb 761 in mice.Phytomedicine, 3,1(1):90-97.
    [51] 肖斯婷, 曹春然, 刘红艳, 等.银杏叶提取物的药学研究进展.中国药事, 2,6(4):429-443.XIAO S T, CAO C R, LIU H Y, et al.Advances in pharmaceutical research of extracts from ginkgo biloba leaves.Chin Pharm Aff, 2,6(4):429-443.
    [52] LIN Y, WANG Z, WANG M, et al.Baicalin attenuate diet-induced metabolic syndrome by improving abnormal metabolism and gut microbiota.Eur J Pharmacol, 2,5:174996.
    [53] RAHIMI V B, ASKARI V R, HOSSEINZADEH H.Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome:a review.Phytother Res, 1,5(7):3558-3574.
    [54] YU X, WANG X, LEI F, et al.Pomegranate leaf attenuates lipid absorption in the small intestine in hyperlipidemic mice by inhibiting lipase activity.Chin J Nat Med, 7,5(10):732-739.
    [55] 赵玉涵, 肖光旭, 范斯文, 等.丹参-川芎药对治疗心脑血管疾病的作用机制及临床研究.中国动脉硬化杂志, 2,0(6):461-469.ZHAO Y H, XIAO G X, FAN S W, et al.Mechanism and clinical study of Danshen-Chuanxiong herbal pair in thetreatment of cardiovascular and cerebrovascular diseases.Chin J Arterioscler, 2,0(6):461-469.
    [56] 周坤, 王静静, 李璐遥, 等.基于AMPKα/SREBP-1/ACCα信号通路调节糖脂代谢的山楂果叶配伍机制研究.西北大学学报(自然科学版), 3,3(1):77-86.ZHOU K, WANG J J, LI L Y, et al.Compatibility mechanism of hawthorn fruit and leaf regulating glycolipid, metabolism based on AMPKα/SREBP-1/ACCα pathway.J Northwest Univ(Nat Sci Ed), 3,3(1):77-86.
    [57] 胡慧明, 朱彦陈, 于城安, 等.山楂、决明子、泽泻提取物对高脂血症大鼠血脂水平、肝功能及HMGCR表达的影响.中成药, 1,3(10):2830-2834.HU H M, ZHU Y C, YU C A, et al.The effects of hawthorn, cassia seed and alisma alisma extract on lipid level, liver function and HMGCR expression in hyperlipidemia rats.Chin Tradit Pat Med, 1,3(10):2830-2834.
    [58] LIU R, SUN Y, DI D, et al.PI3K/Akt/SERBP-1 pathway regulates Alisma orientalis beverage treatment of atherosclerosis in ApoE－/－ high-fat diet mice.Pharm Biol, 3,1(1):473-487.
    [59] 沙琬婧, 朱迪晖, 王田, 等.清脂化瘀方联合阿托伐他汀治疗痰瘀互结证冠心病的临床研究.中西医结合心脑血管病杂志, 2,0(1):86-90.SHA W J, ZHU D H, WANG T, et al.The effect of Qingzhi Huayu prescription combined with atorvastatin on the phlegm-blood stasis syndrome in coronary heart disease.Chin J Integr Med Cardio-Cerebrovasc Dis, 2,0(1):86-90.
    [60] 何国芝.探讨复方山楂汤治疗高脂血症临床疗效.中医临床研究, 8,0(4):43-44.HE G Z.Clinical efficacy of the Fufang Shanzha decoction on hyperlipemia.Clin J Chin Med, 8,0(4):43-44.
    [61] 羊倩倩, 沈德坤.辛伐他汀联合银杏叶胶囊对急性脑梗死伴颈动脉粥样硬化患者的影响.国际老年医学杂志, 3,4(1):41-44.YANG Q Q, SHEN D K.Effect of simvastatin combined with ginkgo biloba capsule on patients with acute cerebral infarction and carotid atherosclerosis.Int J Geriatr, 3,4(1):41-44.
    [62] 汪建芳, 陈瑛瑛.绞股蓝总甙片治疗妊娠合并高脂血症临床研究.新中医, 2,4(2):117-120.WANG J F, CHEN Y Y.Clinical study on Jiaogulanzongdai pian for hyperlipidemia in pregnancy.N Chin Med, 2,4(2):117-120.
    [63] 刘莹莹, 刘伟, 赵永艳, 等.绞股蓝降脂茶治疗高脂血症60例的临床研究.世界最新医学信息文摘, 9,9(92):25-26.LIU Y Y, LIU W, ZHAO Y Y, et al.Dietary therapy of gynostemma pentaphyllum lipid-lowering tea in treating 60 cases of hyperlipidemia.World Latest Med Inform, 9,9(92):25-26.
    引证文献
引用本文

李琴,刘惠美,李兰芳.常见中药在治疗血脂异常中的研究新进展[J].中国动脉硬化杂志,2023,31(7):564~572.

复制
分享
文章指标
  • 点击次数:196
  • 下载次数: 612
历史
  • 收稿日期:2023-02-27
  • 最后修改日期:2023-04-19
  • 在线发布日期: 2023-09-01

您是本站第 4906291 访问者

邮编：421001 传真：0734-8160523

电话：0734-8160765 E-mail：dmzzbjb@163.net

中国动脉硬化杂志 ® 2025 网站版权所有